# A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

> **NCT07470879** · PHASE2 · RECRUITING · sponsor: **Pfizer** · enrollment: 24 (estimated)

## Conditions studied

- Colitis, Ulcerative

## Interventions

- **DRUG:** Etrasimod

## Key facts

- **NCT ID:** NCT07470879
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-30
- **Primary completion:** 2030-09-10
- **Final completion:** 2034-08-20
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07470879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07470879, "A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07470879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*